Progress and Promise Against Cancer Webinar – 2018

Webinar on the latest advances in cancer research featured leading experts discussing highlights from the AACR Cancer Progress Report 2018

The Progress and Promise Against Cancer: 2018 Cancer Progress Report webinar was held on October 11, 2018, and featured leading experts from the American Association for Cancer Research and a patient advocate. During an interactive discussion, they provided highlights from the AACR Cancer Progress Report 2018 and offered their perspectives on the recent successes and future challenges and opportunities for cancer patients, advocates, and researchers.

Published annually, the Cancer Progress Report describes how cancer research is saving lives and how federally funded research discoveries are fueling the development of new and even more effective ways to prevent, detect, diagnose, and treat cancer.

This webinar was hosted by the AACR and Cancer Today, a patient and caregiver magazine published by the AACR.

Cancer Progress Report Webinar Slides

Featured Experts

William G. Nelson, MD, PhD - Moderator

William G. Nelson, MD, PhD – Moderator

Editor-in-Chief of Cancer Today, Marion I. Knott professor of oncology and director of The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University in Baltimore.

Elizabeth M. Jaffee, MD, FAACR

Elizabeth M. Jaffee, MD, FAACR

President of the AACR; chair, AACR Cancer Progress Report 2018; deputy director, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore

Roy S. Herbst, MD, PhD

Roy S. Herbst, MD, PhD

Member, AACR Cancer Progress Report Steering Committee; chair, AACR Tobacco and Cancer Subcommittee; chief of medical oncology, Yale Cancer Center

Mike Delia

Mike Delia

Mike is a cancer survivor who was diagnosed with non-Hodgkin lymphoma in 2014. After his cancer relapsed for the third time, he participated in a clinical trial testing a new CAR T-cell therapy, where his T cells were genetically engineered to attack his cancer. Two years later, Mike is cancer-free and grateful that advancements in cancer research led to his treatment.